This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BackgroundInfective endocarditis (IE) is still a fatal disease, and given its rarity, ongoing updates to patient characteristics and outcomes of IE are essential for providing precision diagnoses and effective treatments. per 100 000 population in 2021. A total of 17 407 patients with IE (37.8% The incidence of IE increased from 2.02
Introduction Data on the characteristics and outcomes of pregnancy and among patients with Fontan physiology are limited. We aimed to evaluate the immediate and long-term outcomes among these patients who were followed at our centre. We examined maternal and obstetric outcomes. We examined maternal and obstetric outcomes.
This study aimed to investigate clinical features, outcomes and optimal management strategies for pregnancy-related AD. Methods We conducted a retrospective multicentre cohort study including 67 women with acute AD during pregnancy or within 12 weeks postpartum from three major cardiovascular centres in China between 2003 and 2021.
In a recent study published in the European Heart Journal, researchers investigated the influence of varying degrees and extent of untreated chronic obstructive CAD on TAVR outcomes and longer-term results. The post Impact of untreated CAD on TAVR outcomes appeared first on Cardiology Update. Original article: Persits I et al.
Although lifestyle changes and risk factor modification are now acknowledged as central components of atrial fibrillation management, the effects of exercise on disease-specific outcomes are still not extensively documented due to few high-quality randomised trials. Trial registration number NCT05164718.
By 2021 almost half of patients younger than 60 years were receiving TAVR rather than SAVR. By 2021 almost half of patients younger than 60 years were receiving TAVR rather than SAVR. years after SAVR to assess their outcomes. The research team followed these patients for a median time of 2.4 years after TAVR and 4.9
The Women’s Health Plan 2021 in Scotland also specifically highlights work on cardiac disease to reach its aim of reducing inequalities in health outcomes for women’s general health.
Material and methods This is a retrospective analysis of the patients with OHCA and return of spontaneous circulation (ROSC) in the community who attended the cardiac catheter laboratory in a DGH between 1 September 2021 and 25 September 2023. Patients with a Glasgow Coma Scale of 15/15 after ROSC were excluded.
Myasthenia gravis is an autoimmune disease with high prevalence of thymus disorders, in which, thymectomy is considered one of the therapeutic approaches in improving the patients’ clinical outcomes. Today, th.
Methods This cohort study included patients diagnosed with AF and prescribed flecainide between 2017 and 2021 in a regional health area. Patients without the polymorphism (H558R–/–) were compared with heterozygous patients (H558R+/–) for a primary outcome of combined 6-month AF recurrence or toxicity.
This report provides findings from a cross-sectional survey of community HF services in the UK between September 2021 and February 2022. Studies are needed to determine if they are adequately resourced to meet population needs and improve patient outcomes. Eighty-five responses describing community HF services were received.
Now, we have a well-validated, non-invasive tool to monitor organ rejection and injury, which has the potential to improve their quality of life and long-term outcomes. "We Short-term clinical outcomes and predicted cost savings of dd-cfDNA-led surveillance after pediatric heart transplantation. 2021 Sep;21 Suppl 3(Suppl 3):17-59.
In this Dutch registry, we investigated MCS usage, associated patient characteristics and clinical outcomes. Methods This real-world, multicentre registry included CS patients undergoing percutaneous coronary intervention between 2017 and 2021 in 14 Dutch hospitals. years and predominantly male (72.8%, n=1613).
They concluded, "Our findings increase confidence in the normal automated GE Marquette 12 SL ECG software interpretation to predict a benign outcome. Smith comment: this is a very stupid outcome measure) What if we use that methodology for the ECG above? What is the gold standard for ECG interpretation: patient outcome!!!
Baseline characteristics, procedural details, and clinical outcomes were compared between the groups.ResultsA total of 189 patients [65.0 Propensity score matching (PSM) was applied to eliminate covariate imbalances. years] were included.
Cox proportional hazards were used to examine the primary outcome of major/CRNM bleeding with an interaction term for treatment*age (75 vs Of 1,287 patients, 625 (49%) were 75 yrs at baseline. 2021 3 Hsu et al. 2021 4 Hsu et al. 2021 5 TIMI Study Group website , AZALEA 71 6 Yi BA et al. 2021 7 Ruff C et al.
Precision Medicine: Personalizing Prevention for Better Outcomes Precision medicine provides tools to customize prevention and treatment plans based on individual risk factors. Precision medicine, primordial prevention, and addressing systemic barriers can improve outcomes and reduce the burden of CVD globally.
Harmony TPV system clinical trials demonstrate ease of implant, conformability to the anatomy, and strong clinical and hemodynamic outcomes for congenital heart disease patients up to three years. Food and Drug Administration approval of the system in 2021. CE Mark follows U.S. Harmony TPV U.S.
As this practice grows, the study highlights the critical need to monitor the effects of private equity acquisitions on quality of care and outcomes for patients with cardiovascular disease, as well as procedural utilization. Acquisitions happened in 20 states; Florida had the most, followed by Texas and Arizona.
Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included. Information on GLD (dispended 6 months before or after coronary angiography) was collected from the Swedish Prescribed Drug Registry.
This study examined trends in their use from 2016 to 2021, the relationship between them, and associated patient demographics and outcomes.Methods:National inpatient Sample (NIS) (n=798,712) was analyzed. Background:Decompressive hemicraniectomy (DHC) and mechanical thrombectomy (MT) are critical interventions for acute ischemic stroke.
The clinical data of adult VAP patients following cardiac valvular surgery from January 2021 to December 2023 were analyzed. Univariable and multivariable logistic regression analyses were performed to identify risk factors for MDRO VAP, and the outcomes of MDRO VAP patients were analyzed.
The 2021 European Society of Cardiology guidelines recommend guideline-directed medical therapy (GDMT) for patients with HF with reduced ejection fraction (HFrEF). Despite proven benefits in reducing morbidity and mortality, many heart failure (HF) patients do not receive optimal guideline-directed medical therapy (GDMT).
The aim of this study was to compare the rate of survival with a good neurologic outcome of patients treated with ECPR meeting all criteria of a clinical decision-making tool for the initiation of ECPR to those for whom ECPR was implemented outside of the algorithm. 8.34); P = 0.45]. 8.34); P = 0.45].
There are conflicting sources regarding the relationship between hyperglycemia and outcomes in STEMI patients. We aimed to compile evidence to assess the association between hyperglycemia and adverse outcomes. Mortality was the most often outcome reported related to hyperglycemia. 3.45) and 4.47 (95% CI: 2.54–7.87),
Studies have consistently shown that procedural optimization guided by IVUS leads to better clinical outcomes compared to angiography-guided PCI alone. Additionally, recent trials suggest similar outcomes between OCT-guided PCI and IVUS-guided PCI. Patients were divided into two groups based on IVI usage.
BackgroundNontraumatic subarachnoid hemorrhage (SAH) presents a significant health burden, yet the influence of social determinants of health on outcomes remains unclear. Outcomes included inhospital death, length of stay, and discharge disposition (good: home/rehabilitation; poor: longterm facility/hospice/death).
Researchers analyze primary and secondary cardiovascular outcomes in 132,784 inpatients with COVID-19 (October 8, 2020 to September 30, 2021) and 31,173 inpatients with non-COVID-19 pneumonia (January 1, 2019 to December 31, 2019) in Korea. The results indicate a lower risk of cardiovascular disease in COVID-19 patients.
Objective To describe the impact of the pandemic on blood pressure screening and hypertension management based on a national quality of care scheme (Quality and Outcomes Framework, QOF) across key demographic, regional and clinical subgroups. million NHS patients registered at general practices (March 2019 to March 2023).
years by 2021 in the U.S.1 The researchers assessed life expectancy trends between 2000 and 2021. Already Stark Differences Widened Further In 2021, Asian Americans living in counties with predominantly Asian populations had the highest life expectancy at 84.0 year drop in life expectancy between 2019 and 2021.
Clotild was designated a breakthrough medical device for use in brain arteries by the FDA in 2021. This critical information empowers physicians to select the most suitable endovascular therapeutic approach, thereby mitigating complications, avoiding embolization, and enhancing long-term treatment outcomes.
Key factors, such as long-lasting outcomes, effective LAA closure and a reduced need for blood-thinning medication, are critical considerations when choosing an LAA closure approach. The findings provide physicians with valuable insights into the long-term benefits of the Amplatzer Amulet for patients at risk of stroke due to AFib.
Methods:We analyzed data on Medicare fee-for-service beneficiaries aged ≥65 years hospitalized with AIS from April 1, 2020, to December 31, 2021. However, limited information exists on how demographic and clinical factors are associated with social inequities among older patients hospitalized with acute ischemic stroke (AIS) during COVID-19.Methods:We
Clinical outcomes in peripheral vascular disease have consistently been shown to benefit from accurate intravascular measurements, yet adoption has been limited by the additional procedure time and training required to interpret images" noted S. J Invasive Cardiol. 2020 Mar;32(3):99-103. 2 Yost, Mary L.,
The association between Veteran status and stroke and associated outcomes have not been well described.Methods:We performed a retrospective, cross-sectional analysis of the 2021 Behavioral Risk Factor Surveillance System. Introduction:Veterans represent a unique population who may be at higher risk of developing stroke.
Ten presentations will feature new data from the pivotal Phase III FINEARTS-HF cardiovascular (CV) outcomes trial, which investigated KERENDIA for treatingt adult patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of 40%, i.e., mildly reduced LVEF (HFmrEF) or preserved LVEF (HFpEF). Additional ACC.25
years]) admitted to the China Chest Pain Center Database between 2016 and 2021. The primary outcome was a composite of inhospital adverse events. Associations between multimorbidity patterns and outcomes were evaluated using multivariableadjusted logistic regression models.
The model projected participants’ cardiovascular risks, survival, quality-adjusted life years (QALYs) and healthcare costs (2021 UK£) with and without lifetime standard (35%–45% low-density lipoprotein cholesterol reduction) or higher intensity (≥45% reduction) statin therapy.
Objective Implantable loop recorders (ILRs) are increasingly used for long-term rhythm monitoring after ischaemic and cryptogenic stroke, with the goal of detecting atrial fibrillation (AF) and subsequent initiation of oral anticoagulation to reduce risk of adverse clinical outcomes.
A comparison between overdose‐attributable OHCA and nonoverdose‐attributable OHCA will inform public health measures.Methods and ResultsWe analyzed data from 2017 to 2021 in the Cardiac Arrest Registry to Enhance Survival (CARES), comparing overdose‐attributable OHCA (OD‐OHCA) with OHCA from other nontraumatic causes (non‐OD‐OHCA).
Over time, the build-up of these proteins causes the heart muscle to stiffen, eventually leading to heart failure, which can have dire outcomes if not found early. Cardiac amyloidosis is a heterogeneous disease that results from the accumulation of abnormal proteins within the heart, impairing its ability to pump blood.
BackgroundDespite robust evidence supporting an association with improved outcomes in eligible patients, cardiac rehabilitation (CR) remains underused, with a minority of eligible patients participating. VCR data were collected from program initiation in July 2021 to September 2023.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
45 
Let's personalize your content